Register entry
AJENAT PHARMACEUTICALS LLC
- Registered sites
- 2
- Drug products
- 13
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackagingRepackaging
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| AJENAT PHARMACEUTICALS LLC | Largo, FLUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging, Repackaging | 3033007964 |
| AJENAT PHARMACEUTICALS LLC | Tampa, FLUnited States | Labelling | 3027254816 |
Catalogue
Marketed products
13Showing 13 of 13.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Dehydrated Alcohol | Alcohol | INJECTION, SOLUTION | NDA |
| Gabapentin | Gabapentin | SOLUTION | ANDA |
| Glatiramer Acetate | glatiramer acetate | INJECTION, SOLUTION | ANDA |
| Glatiramer Acetate | glatiramer acetate | INJECTION, SOLUTION | ANDA |
| Glycopyrrolate Oral Solution | Glycopyrrolate | SOLUTION | ANDA |
| Lacosamide Oral Solution | Lacosamide | SOLUTION | ANDA |
| Phenobarbital Oral Solution | Phenobarbital Oral | SOLUTION | UNAPPROVED DRUG OTHER |
| Potassium Chloride | Potassium Chloride | SOLUTION | ANDA |
| Potassium Chloride | Potassium Chloride | SOLUTION | ANDA |
| Potassium Chloride for Oral Solution | Potassium Chloride for Oral Solution | POWDER, FOR SOLUTION | ANDA |
| Tacrolimus | Tacrolimus | CAPSULE | ANDA |
| Tacrolimus | Tacrolimus | CAPSULE | ANDA |
| Tacrolimus | Tacrolimus | CAPSULE | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.